HIGH-CONCENTRATION ANTIBODY FORMULATIONS DIRECTED AGAINST BETA-AMYLOI PEPTIDE PROTOFIBRILLS AND THEIR METHODS OF USE
MA62357B1Active Publication Date: 2026-09-30EISAI R&D MANAGEMENT CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA62357
- Authority / Receiving Office
- MA · MA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-03-19
- Filing Date
- 2021-03-19
- Publication Date
- 2026-09-30
- Estimated Expiration
- 2041-03-19
Abstract
Aqueous pharmaceutical formulations are provided here comprising high concentrations of an isolated anti-protofibril Aβ antibody or a fragment thereof that binds to human Aβ protofibrils, such as BAN2401, arginine, polysorbate 80 and a pharmaceutically acceptable buffer.
Need to check novelty before this filing date? Find Prior Art